SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates using an alpha–particle emitting radioisotope, actinium–225, for potential cancer treatments The two sides aim to submit an Investigational New Drug application […]
#Rosal Top Picks
Recent Posts
- With over two decades of experience, Foley will focus
- Skylark Labs, recognized for its progressive adaptive
- PITTSBURGH, March 14, 2025 /PRNewswire/ —
- – Income higher 12% to $21 million for the 3rd
- Bioretec Ltd Press Release 14 March 2025 at